A 52-year-old Indian woman with newly diagnosed POAG is counseled about first-line pharmacological management. Her IOP is 28 mmHg bilaterally, and she has no contraindications to any drug class. Which of the following is NOT recommended as a first-line monotherapy agent for POAG according to current guidelines?

See the options, answer & explanation

Sign in free to reveal the answer choices, the correct answer, the detailed explanation, and AI-powered insights for this question.